[1] Hook III EW. Syphilis. Lancet, 2017; 389, 1550−7. doi:  10.1016/S0140-6736(16)32411-4
[2] Tao YS, Chen MY, Tucker JD, et al. A nationwide spatiotemporal analysis of syphilis over 21 years and implications for prevention and control in China. Clin Infect Dis, 2020; 70, 136−9. doi:  10.1093/cid/ciz331
[3] Targa Martins R, Castilhos RM, Silva da Silva P, et al. Frequency of screening and prevalence of neurosyphilis in stroke population. Cerebrovasc Dis, 2020; 49, 301−6. doi:  10.1159/000508491
[4] Du FZ, Zhang HN, Li JJ, et al. Neurosyphilis in China: a systematic review of cases from 2009-2021. Front Med (Lausanne), 2022; 9, 894841.
[5] Gonzalez H, Koralnik IJ, Marra CM. Neurosyphilis. Semin Neurol, 2019; 39, 448−55. doi:  10.1055/s-0039-1688942
[6] Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med, 2019; 380, 2327−40. doi:  10.1056/NEJMoa1803396
[7] Xing XW, Zhang JT, Ma YB, et al. Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a large, prospective case series of 213 patients. Front Cell Infect Microbiol, 2020; 10, 88. doi:  10.3389/fcimb.2020.00088
[8] Ropper AH. Neurosyphilis. N Engl J Med, 2019; 381, 1358−63. doi:  10.1056/NEJMra1906228
[9] Drago F, Ciccarese G, Broccolo F, et al. A new enhanced antibiotic treatment for early and late syphilis. J Glob Antimicrob Resist, 2016; 5, 64−6. doi:  10.1016/j.jgar.2015.12.006
[10] Ji XC, Zhou LF, Li CY, et al. Reduction of human DNA contamination in clinical cerebrospinal fluid specimens improves the sensitivity of metagenomic next-generation sequencing. J Mol Neurosci, 2020; 70, 659−66. doi:  10.1007/s12031-019-01472-z